MESO
MesoblastยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MESO Profile
Mesoblast Limited
A global leader in allogeneic cellular medicines for inflammatory diseases
Biological Technology
06/08/2004
11/13/2015
NASDAQ Stock Exchange
81
06-30
Depository Receipts (Ordinary Shares)
Level 38, 55 Collins Street, Melbourne , VIC, 3000, Australia
A biotechnology company in the field of adult stem cell technology
Mesoblast Limited was established in Australia on June 8, 2004. The company is a world leader in the development of allogeneic cell drugs. The company has built a broad portfolio of commercial and late-stage product candidates utilizing its proprietary mesenchymal spectrum cell therapy technology platform.
